Eir Partners Closes Oversubscribed $496 Million Investment Program II
Eir Partners Closes Oversubscribed $496 Million Investment Program II
Dedicated Investment Program II Will Further Eir Partners' Strategy of Partnering with Companies Across the Healthcare Technology & Technology Enabled Services Marketplace
第二期專項投資計劃將進一步推動Eir Partners與醫療保健技術和技術支持服務市場的公司合作的戰略
MIAMI, May 21, 2024 /PRNewswire/ -- Eir Partners Capital, LLC ("Eir", "Eir Partners" or the "Firm"), a middle market private equity firm focused on healthcare technology and tech-enabled services, today announced the final closing of Eir Partners Investment Program II with $496 million in capital commitments. Eir previously raised $255 million in capital commitments for its inaugural program, Eir Partners Program I, which closed in 2021 and invested in five platform investments.
邁阿密，2024年5月21日 /PRNewswire/ — 專注於醫療保健技術和技術支持服務的中間市場私募股權公司Eir Partners Capital, LLC（“Eir”、“Eir Partners” 或 “公司”）今天宣佈Eir Partners第二投資計劃的最終結束，資本承諾爲4.96億美元。Eir此前爲其首個計劃Eir Partners I計劃籌集了2.55億美元的資本承諾，該計劃於2021年結束，投資了五項平台投資。
The oversubscribed program was raised in less than four months and secured commitments from a diversified range of investors including leading financial institutions, insurance companies, family offices, funds-of-funds, endowments and foundations, and seasoned industry executives.
這項超額認購計劃在不到四個月的時間內籌集到資金，並獲得了包括領先金融機構、保險公司、家族辦公室、基金會、捐贈基金和基金會以及經驗豐富的行業高管在內的多元化投資者的承諾。
"We are thrilled to receive support from a distinguished group of investors to continue our strategy of partnering with exceptional businesses and teams," said Brett Carlson, Founder & Chief Executive Officer of Eir Partners. "Their commitment will help grow and establish Eir as a leading health-tech investment firm in the market."
Eir Partners創始人兼首席執行官佈雷特·卡爾森表示：“我們很高興得到傑出投資者的支持，以繼續我們與卓越企業和團隊合作的戰略。”“他們的承諾將有助於發展和確立Eir作爲市場上領先的健康科技投資公司的地位。”
Eir Partners Investment Program II will continue to invest in disruptive companies that have proven market fit and scale demonstrating outsized organic growth potential coupled with accretive M&A opportunities. Eir seeks to partner with businesses where the firm's operating experience and executive advisor network can make an impact across all aspects of the business including technology, finance, sales, and human capital.
Eir Partners投資計劃二期將繼續投資具有市場契合度和規模的顛覆性公司，這些公司的有機增長潛力巨大，並有更多的併購機會。Eir尋求與公司的運營經驗和執行顧問網絡可以對業務的各個方面（包括技術、金融、銷售和人力資本）產生影響的企業合作。
Lazard Frères & Co. LLC acted as the exclusive placement advisor, and Kirkland & Ellis LLP served as legal counsel in the formation of Eir Partners Investment Program II.
Lazard Freères & Co.有限責任公司擔任獨家配售顧問，Kirkland & Ellis LLP在Eir Partners投資計劃II的組建中擔任法律顧問。
About Eir Partners
關於 Eir Partners
Eir Partners Capital, LLC is a Miami-based private equity company focused exclusively on healthcare technology and tech- enabled services. Eir combines its operational expertise with bottoms up thematic sourcing efforts to accelerate value creation. Since inception, Eir has completed transactions across payer, provider, employer and pharma tech, including leading industry names such as Apixio, Capta, GiftHealth, Helpware, and ReviveHealth. Targeted stages of investment include growth equity through control buyouts and equity check sizes range from $25 - $100 million.
Eir Partners Capital, LLC是一家總部位於邁阿密的私募股權公司，專門從事醫療保健技術和技術支持服務。Eir將其運營專業知識與自下而上的主題採購工作相結合，以加速價值創造。自成立以來，Eir已經完成了跨支付方、提供商、僱主和製藥科技公司的交易，包括Apixio、Capta、GiftHealth、Helpware和ReviveHealth等領先的行業公司。目標投資階段包括通過控制權收購實現的成長型股權，股票支票規模從2500萬美元到1億美元不等。
For more information, please visit the Eir Partners website at or the Eir Partners LinkedIn page at
欲了解更多信息，請訪問 Eir Partners 網站或 Eir Partners LinkedIn 頁面
Contact
聯繫我們
Chris Tofalli
Chris Tofalli Public Relations, LLC
914-834-4334
[email protected]
克里斯·託法利
克里斯·託法利公共關係有限責任公司
914-834-4334
[電子郵件保護]
SOURCE Eir Partners
來源 Eir Partners
譯文內容由第三人軟體翻譯。